Fundamental dimension Equity attribute | AMTPeer $188.97▲+4.08% Cap $88.05BP/E 26.0x QuantScore57/100 | CCIPeer $85.97▲+9.05% Cap $37.57BP/E 35.8x QuantScore49/100 | CHWRFLeader $1.160.00% Cap $20.28BP/E 9.7x QuantScore67/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
78/100 |
77/100 |
75/100 |
Valuation Multiples, PEG & DCF upside | 75/100 | 58/100 | 96/100 |
Health Piotroski, Altman Z, leverage & liquidity | 20/100 | 37/100 | 56/100 |
Growth Revenue / earnings growth & margins | 37/100 | 37/100 | 9/100 |
Sentiment Analyst ratings, targets & revisions | 76/100 | 39/100 | 100/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 26.0x | 35.8x | 9.7x |
Forward P/E (next FY) | 27.1x | 44.5x | 1.4x |
EV / EBITDA (TTM) | 18.7x | 22.6x | 3.8x |
Price / Sales | 8.0x | 9.2x | 1.3x |
Price / Free Cash Flow | 22.2x | 20.0x | 21.3x |
PEG ratio | 0.16 | 0.09 | 0.48 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 7 / 9 | 7 / 9 | 8 / 9 |
Altman Z-Score | 1.21 (Distress) | -0.11 (Distress) | 1.22 (Distress) |
Total debt / equity | 12.09 | -6.69 | 0.49 |
Quick ratio | 0.4x | 0.2x | 1.8x |
Interest coverage | 4.6x | 2.2x | 10.2x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +5.1% | -35.1% | +0.0% |
Net income growth YoY | +12.2% | +111.4% | +5.6% |
Gross margin (TTM) | 73.2% | 63.0% | 9.6% |
Operating margin (FY) | 45.8% | 48.7% | 17.1% |
FCF margin (FY) | 35.5% | 67.4% | 26.2% |
5. Trailing price performancePrice change over period |
1M return | +11.8% | +26.7% | +26.4% |
3M return | +13.4% | +14.8% | +5.5% |
6M return | +6.0% | -0.4% | -20.0% |
Year to date | +7.6% | -3.3% | -11.5% |
1Y return | -0.4% | -11.9% | +17.8% |
3Y return | +16.7% | -1.5% | +28.9% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $188.38 -0.3% premium | $-19.67 -122.9% premium | $7.47 +544.2% upside |
Wall Street consensus target | $209.78 +11.0% · range $188.00–$240.00 | $89.25 +3.8% · range $84.00–$95.00 | — — |
Consensus stance | 82% Buy18% Hold0% Sell | 53% Buy45% Hold2% Sell | 100% Buy0% Hold0% Sell |